Skip to content
DexCom logo

DexCom

DXCM

DexCom is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Jacob Steven Leach, with a market cap of $28.6B.

Market cap
$28.58B-12.1%
Revenue$4.8B+16.2%
Net income$930.4M+73.8%
Free cash flow$1.4B+149%
EPS (diluted)$2.33+73.9%
Trailing twelve months · change vs. prior year

Earnings

Next report

Jul 29, 2026 (In 2 weeks)
Revenue estimate$1.3B
EPS estimate$0.61

Financials

Q1 2026

Income statement

See full
Revenue$1.2B+15.0%
Gross profit$750.3M+27.4%
Operating income$255.3M+90.9%
Net income$199.5M+89.3%
EPS (diluted)$0.51+88.9%

Balance sheet

See full
Cash & equivalents$1.1B+23.4%
Total debt$143.0M+2.2%
Total equity$3.0B+30.5%
Total assets$6.6B-1.8%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation & ratios

Valuation

See full
Market cap$28.58B-12.1%
Enterprise value$27.6B-12.3%
P/E30.7×-26.2×
P/S5.9×-1.6×

Profitability

See full
Gross margin61.5%+2.1pp
Operating margin21.4%+6.2pp
Net margin19.3%+6.4pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity35.6%+11.9pp
Debt / equity0.0×
Current ratio1.9×+0.4×

Profile

Listed2005
Employees9.6K
CEOJacob Steven Leach
Websitedexcom.com
FilingsSEC EDGAR

Questions, answered.

What is DexCom's market cap?
DexCom (DXCM) has a market capitalization of $28.6B and trades on NASDAQ.
What is DexCom's revenue and profitability?
DexCom generated $4.8B in trailing twelve-month revenue with net income of $930.4M, representing a net margin of 19.3%. Gross margin stands at 61.5%, with free cash flow of $1.4B. These figures are based on the Q1 2026 filing.
Where is DexCom headquartered?
DexCom is headquartered in United States of America and employs approximately 9,600 people. It has been publicly traded since 2005.